A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
